These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3052824)

  • 1. Serotonergic mechanisms of depression.
    Curzon G
    Clin Neuropharmacol; 1988; 11 Suppl 2():S11-20. PubMed ID: 3052824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic dysfunction in depression.
    Meltzer H
    Br J Psychiatry Suppl; 1989 Dec; (8):25-31. PubMed ID: 2692637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic activity in man as a function of pain, pain mechanisms, and depression.
    Ghia JN; Mueller RA; Duncan GH; Scott DS; Mao W
    Anesth Analg; 1981 Dec; 60(12):854-61. PubMed ID: 6172060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin activity in psychotic (delusional) major depression.
    Schatzberg AF; Rothschild AJ
    J Clin Psychiatry; 1992 Oct; 53 Suppl():52-5. PubMed ID: 1429484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A scale for clinical evaluation of serotonergic deficit in elderly people].
    Aubin-Brunet V
    Encephale; 1993 Jul; 19 Spec No 2():413-6. PubMed ID: 8281907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serotonin receptor changes in depression: evidences and limitations].
    Gómez E; Catalán R; Navinés R; Gastó C
    Actas Esp Psiquiatr; 2001; 29(3):186-94. PubMed ID: 11412493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.
    Jans LA; Riedel WJ; Markus CR; Blokland A
    Mol Psychiatry; 2007 Jun; 12(6):522-43. PubMed ID: 17160067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the 5-HT neurotransmission by antidepressant treatments.
    De Montigny C
    J Physiol (Paris); 1981; 77(2-3):455-61. PubMed ID: 6270317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression.
    Grønli J; Fiske E; Murison R; Bjorvatn B; Sørensen E; Ursin R; Portas CM
    Behav Brain Res; 2007 Jul; 181(1):42-51. PubMed ID: 17477980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity of depression and panic disorder.
    Gorman JM; Coplan JD
    J Clin Psychiatry; 1996; 57 Suppl 10():34-41; discussion 42-3. PubMed ID: 8917130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response.
    Cryan JF; Leonard BE
    Hum Psychopharmacol; 2000 Mar; 15(2):113-135. PubMed ID: 12404340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.